What Is Driving ISpecimen Stock Up 7%?

Shares of iSpecimen Inc. (ISPC) are gaining over 7% on Thursday morning after the company announced that it has expanded support of COVID-19 research with availability of sequenced specimens to detect variants.

ISPC is currently trading at $7.34, up $0.51 or 7.47%, on the Nasdaq.

iSpecimen announced the expansion of its supplier capabilities with the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research, including analyzing the Omicron and Delta variants. The reference lab, a recent addition to the iSpecimen supplier network, has the capacity to sequence hundreds of COVID-19 positive swabs per week, providing data that is crucial in the fight against the virus. This lab is sequencing the most recent swabs to identify new variants of COVID-19 as the virus continues to progress globally.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Follow RTT